JPRN-UMIN000025975已完成未知
Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain - Exploratory study of optimal conditions of non-invasive brain stimulation for intractable pain
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with dementia (MMSE=<24) 2)Patients with severe aphasia or higher brain dysfunction 3)Patients with a major psychiatric disease 4)Patients with a desire for suicide 5)Patients with a history of epileptic attacks 6)Patients with an implantable cardiac stimulator 7)Patients with an implantable deep brain stimulation devices 8)Patients with an implanted metal in their heads, except for titanium products 9)Pregnant patients 10)Patients who cannot write questionaires 11)Patients without ability of agreements 12)Patients receiving other clinical trials or studies within 6 months before agreements 13)Patients who are considered unsuitable for this clinical trial by a principal or sub investigator 14)Patients with a scalp lesion on the stimulation site (tDCS)
研究者
相似试验
招募中
Unknown
A reseach of the optimal condition for the transportation of teethtooth extraction for orthodontic treatmentJPRN-jRCT1030220552Hoshi Kazuto50
招募中
不适用
Investigation of the optimal condition for intraoperative cholangiography using indocyanine greeHepatobiliary diseaseJPRN-UMIN000046239Kyoto Katsura Hospital, Surgery50
招募中
4 期
A Study for Finding Optimal Indication for Cicrosporine A in Patients with Kawasaki DiseaseJPRN-jRCTs031230101Hamada Hiromichi320
已完成
不适用
A study to understand the applicability of OPtimal Treatment of Angina (OPTA) questionnaire in patients with stable ischemic heart diseaseCTRI/2021/07/035263Abbott Healthcare Pvt Ltd354
已完成
不适用
A pilot study to verify the optimal condition under Cell-free and Concentrated Ascites Reinfusion Therapy (CART) to deal with huge amount of the malignant ascitesJPRN-UMIN000032619Cancer Institute Hospital Gastroenterological Chemotherapy Department100